Transcript Slide 1

Methodology for Adaptive Treatment Strategies
R21 DA019800
The Goal
Susan Murphy, PI
To facilitate methodological collaborations necessary for
producing evidence-based adaptive treatment strategies.
This network involves engineers, computer scientists,
psychologists, physicians and statisticians interested in
forming collaborate groups which will conduct the necessary
research and pilot studies so as to apply for R03 or R01
funding. Our long term goal is to enhance the adaptive,
sequential, clinical decision making necessary in
treating/managing chronic, relapsing disorders.
University of Michigan
What are Adaptive Treatment Strategies?
Adaptive Treatment Strategies are individually tailored
sequences of treatments, with treatment type and dosage
adapted and readapted to the individual.
• Generalization from a one-time decision to a sequence of
decisions concerning treatment
• Operationalize clinical practice
Example of an Adaptive Treatment Strategy
If high risk, then provide biweekly court hearings.
Innovations
 Intervention Trial Design
Sequential, Multiple Assignment, Randomized Trials
Else maintain on current treatment.
8 wks
Responder
2nd Tx
R
rRBT
Generalization of regression from one stage of treatment to
multiple stages of treatment.
aRBT
rRBT
rRBT
tRBT
CATIE (simplified version)
R
Responder
R
1st Tx
rRBT
SMART
Precursors are STAR*D (depression) and CATIE
(schizophrenia) (NIMH funded)
Identify a few critical decisions, randomize individuals at
each critical decision among treatment options.
Critical decisions include: Which treatment to use first?,
How long to wait for the treatment to work?, Which
treatment to provide next?
Olan
Timing
R
Zip
Other SMART Studies
Sequencing Pharmacology and Behavioral Interventions
Risp
in ADHD. Pelham, PI; IES
Perp
Early
Trigger
NonR
Responder
NTX
NTX+TDM
CBI
NTX+CBI
Children. Kasari, PI; Autism Speaks
Analyses of SMART Studies
Compare two adaptive treatment strategies
Compare outcomes from blue and green groups!
NTX R
R
Late
Trigger
NTX
NTX+TCM
CBI
NonR
Responder
NTX+CBI
Cloz
NonResp.
Efficacy
R
Other
Tolerance R
Olan
Quet
Zip
Risp
Sequencing Behavioral Treatments for Nonverbal Autistic
2nd Tx
R
Quet
tRBT
Adaptive Aftercare for Alcoholism. McKay PI, NIAAA
SMART Study (ExTENd; Oslin, PI: NIAAA)
Responder
Same
Tx
Resp.
Sequencing Treatments for Prostate Cancer. Millikan, PI
Responder
2nd Tx
tRBT
NonR
Responder
1st Tx
Preference
tRBT
eRBT
Monitor compliance and symptoms monthly.
If offender becomes non-responsive, then provide intensive
case management along with assessment and referral for
adjunctive services.
1st Tx
NonR
Responder
(SMART)
 Intervention Trial Data Analysis
Q-Learning
Exploratory Tailoring Analyses
Else provide “as-needed court hearings.”
If the offender becomes noncompliant, then the offender is
subject to a court determined disposition.
strategies that use more than simply response/non-response
to adapt treatment to the individual.
SMART Study II (RBT; Jones, PI; NIDA)
(Drug Court Program for drug abusing offenders.)
Provide standard drug counseling
Q-Learning: A method from Computer Science
Can be used to construct proposals for adaptive treatment
Construct more deeply tailored strategies:
Should the level of adherence during 1st treatment
2nd
be used to select
treatment?
Should severity of disorder influence which
treatment should be 1st?
Q-Learning--Example of Results using CATIE
Begin with Olanzapine
If non-responder then
 If preference is try for efficacy then
 If PANSS > 94 then switch to Clozapine
 Else switch to either Quetiapine or Risperidone
 If preference is to try for tolerability then
 If Olanzapine was not tolerable then switch to
Risperidone
 If Olanzapine was not efficacious then switch to
Quetiapine
PANSS: Positive and Negative Syndrome Scale
Acknowledgements: MCAT network and NIH